Pediatric idiopathic anaphylaxis: experience with 22 patients

Area of Science:

• Pediatric Allergy and Immunology
• Clinical Immunology

Background:

• Idiopathic anaphylaxis (IA) is increasingly recognized in children.
• Pediatric IA shares symptomology and classification with adult cases.
• Unique considerations exist for managing IA in the pediatric population.

Purpose of the Study:

• To describe the clinical presentation and management of idiopathic anaphylaxis in a pediatric cohort.
• To highlight management strategies and challenges specific to pediatric patients.

Main Methods:

• Retrospective case series of 22 pediatric patients diagnosed with idiopathic anaphylaxis.
• Review of treatment protocols including prednisone, hydroxyzine, and albuterol.
• Analysis of patient outcomes and complicating factors.

Main Results:

• All 22 pediatric patients received treatment with prednisone, hydroxyzine, and albuterol.
• Symptom control and remission were achieved in the studied cohort.
• No fatalities were reported during the treatment period.
• One adolescent case presented with corticosteroid-dependent IA, later diagnosed as undifferentiated somatoform-IA.
• Challenges in patient care were noted due to physician reluctance to participate in management.

Conclusions:

• Idiopathic anaphylaxis in children can be effectively managed with a combination of prednisone, hydroxyzine, and albuterol.
• While IA symptoms are similar across age groups, pediatric-specific management approaches are crucial.
• Addressing physician engagement and potential somatoform components are important for comprehensive care in pediatric IA.